ScreenerHero

CEROCERo Therapeutics Holdings Inc. Common Stock

NAS · US · Healthcare · Biotechnology · cero.bio
0.0100USD-6.54%Mkt Cap: 716309 $P/E: 0.00

CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T …

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap716.31K $
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-19.92M $
Revenue/Share—
Last Price0.0100 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees8
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.02
EPS (TTM)9.34
EPS (Forward)-3.26
52W Range
0.00750% of range8.900
52W High8.900 USD
52W Low0.0075 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE365.75%
ROA-547.09%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.08M $
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.13
Current Ratio—
Quick Ratio—
Book Value/Sh-0.6020 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJun 13, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.71.63M
Float—
Insiders2.60%
Institutions0.09%
Short Interest
Short Ratio0.8d
Short % Float10.50%
Short % Out.10.34%
Shares Short192.89K
Short (prev mo.)106.18K
Technical
SMA 500.0111 (-9.7%)
SMA 2000.0400 (-75.0%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)384.07K
Avg Vol (10d)328.61K
Technical Indicators
RSI (14)46.9
MACD-0.0004
MACD Signal-0.0006
MACD Hist.+0.0002
BB Upper0.0124 USD
BB Middle0.0102 USD
BB Lower0.0080 USD
BB Width43.27%
ATR (14)0.0021 USD
Vol Ratio (20d)0.09x